Apollo Hospitals Sets Dates for FY26 Earnings and Investor Call

Apollo Hospitals Enterprise Ltd announced it will release its audited financial results for the fourth quarter and the full fiscal year ending March 31, 2026, on May 20, 2026. A conference call for investors and analysts to discuss these results is scheduled for May 21, 2026, at 3:00 PM IST.

Investor Timeline Established

The announcement provides investors with a clear timeline to anticipate the company's financial performance update for the fiscal year 2025-2026. The scheduled investor call offers a direct channel for shareholders and analysts to engage with Apollo Hospitals' management, discuss the reported figures, and seek further insights into the company's strategic direction and operational achievements.

Company Background

Apollo Hospitals Enterprise Ltd is recognized as India's largest private healthcare provider. Its extensive operations encompass multi-specialty hospitals, diagnostics services, and pharmacy retail. The company has historically shown strong revenue growth and operational performance, driven by increasing patient volumes and strategic expansion across its business segments.

Competitive Landscape

Apollo Hospitals operates within a competitive healthcare sector. Key competitors include Max Healthcare Institute Ltd. and Fortis Healthcare Ltd., both of which are also actively expanding hospital networks and focusing on operational efficiency.

Previous Financial Performance Highlights

For the fiscal year 2023-2024, Apollo Hospitals reported consolidated revenue of approximately ₹17,800 crore. Consolidated Profit After Tax (PAT) for the same period ranged between ₹2,000 crore and ₹2,500 crore.

Risk Commentary

The company's announcement did not detail any specific risks related to this earnings disclosure.

Looking Ahead

Investors will now focus on the upcoming earnings announcement and conference call. Key details to monitor include the financial figures for Q4 and the full fiscal year, management's commentary on growth drivers and future outlook, and the market's reaction to the disclosed results and guidance.